158 related articles for article (PubMed ID: 35419830)
1. Impact of pre-emptive rapid testing for glucose-6-phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: A retrospective study.
Ganapathi M; Campbell P; Ofori K; Aggarwal V; Francis RO; Kratz A
Br J Clin Pharmacol; 2022 Sep; 88(9):4163-4170. PubMed ID: 35419830
[TBL] [Abstract][Full Text] [Related]
2. Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
Madanat L; Schoenherr D; Wey E; Gupta R
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33727299
[TBL] [Abstract][Full Text] [Related]
3. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Belfield KD; Tichy EM
Am J Health Syst Pharm; 2018 Feb; 75(3):97-104. PubMed ID: 29305344
[TBL] [Abstract][Full Text] [Related]
4. Methemoglobinemia induced by rasburicase in a pediatric patient: a case report and literature review.
Ng JS; Edwards EM; Egelund TA
J Oncol Pharm Pract; 2012 Dec; 18(4):425-31. PubMed ID: 22190578
[TBL] [Abstract][Full Text] [Related]
5. Hemolysis and methemoglobinemia secondary to rasburicase administration.
Browning LA; Kruse JA
Ann Pharmacother; 2005 Nov; 39(11):1932-5. PubMed ID: 16204390
[TBL] [Abstract][Full Text] [Related]
6. Rasburicase-Induced Methemoglobinemia in a Patient with Glucose-6- Phosphate Dehydrogenase Deficiency.
Khan M; Paul S; Farooq S; Oo TH; Ramshesh P; Jain N
Curr Drug Saf; 2017; 12(1):13-18. PubMed ID: 28078984
[TBL] [Abstract][Full Text] [Related]
7. Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency.
Cheah CY; Lew TE; Seymour JF; Burbury K
Acta Haematol; 2013; 130(4):254-9. PubMed ID: 23860572
[TBL] [Abstract][Full Text] [Related]
8. Catalase deficiency may complicate urate oxidase (rasburicase) therapy.
Góth L; Bigler NW
Free Radic Res; 2007 Sep; 41(9):953-5. PubMed ID: 17729111
[TBL] [Abstract][Full Text] [Related]
9. I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency.
Reeves DJ; Saum LM; Birhiray R
Am J Health Syst Pharm; 2016 May; 73(9):e238-42. PubMed ID: 27099330
[TBL] [Abstract][Full Text] [Related]
10. Methaemoglobinaemia and haemolysis after rasburicase administration in a patient with G6PD deficiency.
Boussaid I; Mondesir J; Chapuis N; Birsen R
BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36198433
[No Abstract] [Full Text] [Related]
11. Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype.
Relling MV; McDonagh EM; Chang T; Caudle KE; McLeod HL; Haidar CE; Klein T; Luzzatto L;
Clin Pharmacol Ther; 2014 Aug; 96(2):169-74. PubMed ID: 24787449
[TBL] [Abstract][Full Text] [Related]
12. Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase.
Bontant T; Le Garrec S; Avran D; Dauger S
BMJ Case Rep; 2014 Aug; 2014():. PubMed ID: 25115783
[TBL] [Abstract][Full Text] [Related]
13. Single 6-mg dose of rasburicase: The experience in a large academic medical center.
Nauffal M; Redd R; Ni J; Stone RM; DeAngelo DJ; McDonnell AM
J Oncol Pharm Pract; 2019 Sep; 25(6):1349-1356. PubMed ID: 30111244
[TBL] [Abstract][Full Text] [Related]
14. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Youngster I; Arcavi L; Schechmaster R; Akayzen Y; Popliski H; Shimonov J; Beig S; Berkovitch M
Drug Saf; 2010 Sep; 33(9):713-26. PubMed ID: 20701405
[TBL] [Abstract][Full Text] [Related]
15. Mortality following rasburicase-induced methemoglobinemia.
Bucklin MH; Groth CM
Ann Pharmacother; 2013 Oct; 47(10):1353-8. PubMed ID: 24259700
[TBL] [Abstract][Full Text] [Related]
16. Study of Glucose-6-Phosphate Dehydrogenase Deficiency: 5 Years Retrospective Egyptian Study.
Hagag AA; Badraia IM; Elfarargy MS; Abd Elmageed MM; Abo-Ali EA
Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):155-162. PubMed ID: 28982343
[TBL] [Abstract][Full Text] [Related]
17. Comparative evaluation of single fixed dosing and weight-based dosing of rasburicase for tumor lysis syndrome.
McBride A; Lathon SC; Boehmer L; Augustin KM; Butler SK; Westervelt P
Pharmacotherapy; 2013 Mar; 33(3):295-303. PubMed ID: 23456733
[TBL] [Abstract][Full Text] [Related]
18. Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Before Rasburicase Use for Tumor Lysis Syndrome.
Lakra R; Grewal US; Ramadas P
Am J Ther; 2023 Sep-Oct 01; 30(5):e465-e467. PubMed ID: 37713696
[No Abstract] [Full Text] [Related]
19. Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase.
Sonbol MB; Yadav H; Vaidya R; Rana V; Witzig TE
Am J Hematol; 2013 Feb; 88(2):152-4. PubMed ID: 22573495
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
